Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Fasken ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
Canada
16 Jul 2019
2
New Mandatory Reporting Requirements For Hospitals
On June 26, 2019, the federal government, under the authorities granted by the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law), adopted new mandatory reporting requirements for hospitals across the country.
Canada
16 Jul 2019
3
2019 Federal Budget Life Sciences Highlights
On March 19, 2019, federal Finance Minister William Morneau tabled the latest federal budget in the House of Commons ("Budget 2019"),
Canada
25 Apr 2019
4
When Is Software A Medical Device?
Once it has been established that a software technology is indeed a medical device, classification must then be determined.
Canada
14 Feb 2019
5
Québec Court Of Appeal Strikes Down Federal Genetic Non-Discrimination Act
On May 4, 2017, the Genetic Non-Discrimination Act (Act) received royal assent and came into force, despite the federal Minister of Justice's opinion that the Act was unconstitutional.
Canada
30 Jan 2019
6
Health Canada Announces Medical Device Safety Action Plan And Publishes Draft Guidance On Cybersecurity
This update is intended for medical device manufacturers and those interested in the regulation of medical devices
Canada
22 Jan 2019
7
PAAB Gets Real
This update is intended for drug companies who market their products to healthcare professionals.
Canada
21 Dec 2018
8
ISDE Annonce Un Investissement De 950 Millions De Dollars Dans Les Supergrappes Canadiennes
Les demandeurs doivent être des consortiums dirigés par l'industrie et inclure des entreprises de toutes tailles incluant au moins un établissement d'enseignement postsecondaire.
Canada
27 Jun 2017
9
From Diplopia To Double Vision: Health Canada’s Plain Language Labeling Project Is A Sight For Sore Eyes
According to Health Canada, over-crowded and confusing drug labels, unclear instructions, and similarities between packages and names are the primary cause of medication errors in Canada.
Canada
26 Jul 2013
10
Patent Exhaustion Does Not Allow A Purchaser To Make New Copies Of Patented Seeds
In a concise unanimous decision, the Supreme Court of the United States has ruled in favor of Monsanto against a farmer who reproduced patented seeds by planting and harvesting second generation seeds without Monsanto's permission.
Canada
17 May 2013
11
No More Exemptions For Unlicensed Natural Health Products
Last month marked the end of the "Natural Health Products (Unprocessed Product Licence Applications) Regulations".
Canada
14 Mar 2013
12
Provinces And Territories Take First Step On A Pan-Canadian Approach To Management Of Drug Costs
On January 18, 2013, the Canadian provinces and territories (with the exception of Quebec) announced a joint initiative designed to achieve significant cost savings for publicly funded drug plans.
Canada
25 Jan 2013
13
Griffiths Energy International Inc. Announces Bribery Charges - A Prosecution To Watch
On January 15, 2013, Calgary-based Griffiths Energy International Inc. ("Griffiths") announced that it has been charged under Section 3(1)(b) of Canada’s Corruption of Foreign Public Officials Act ("CFPOA").
Canada
24 Jan 2013
14
Proposed Prescription Drug List Available For Public Consultation
The List sets out drugs and classes of drugs that are divided based on medicinal ingredients for human and veterinary use.
Canada
15 Jan 2013
15
Canada’s Clinical Trial Infrastructure: A National Framework For Coordinating Clinical Trials
The Standing Senate Committee on Social Affairs, Science and Technology released a report in November (2012) entitled Canada's Clinical Trial Infrastructure: A Prescription for Improved Access to New Medicines, which paints a dreary picture of the health of the Canadian pharmaceutical R&D landscape.
Canada
28 Dec 2012
16
Sign Of Life: Life Sciences Bulletin Board - December 4, 2012
Over 80 million dollars' worth of counterfeit pharmaceuticals were seized over a three-day period last July in several African ports at the close of an international customs operation.
Canada
12 Dec 2012
17
Teva v Pfizer, Or The "Viagra Saga": If There Is No Quid — Proper Disclosure — There Can Be No Quo — Exclusive Monopoly Rights
Sildenafil is the active ingredient in Viagra, the blockbuster potency-enhancing drug marketed by Pfizer.
Canada
27 Nov 2012
18
Crossing Borders: The Inclusion Of Foreign Drug Reviews In Canadian Data Packages
In October 2011, Health Canada implemented a pilot project for the use of foreign review assessment information when evaluating health products seeking market authorization in Canada.
Canada
30 Oct 2012
19
Supreme Court Of Canada Decides Transfer Pricing Case - Canada v. GlaxoSmithKline Inc.
In its recently-released judgement in Canada v. GlaxoSmithKline Inc.[1] the Supreme Court of Canada has considered transfer pricing tax issues for the first time.
Canada
25 Oct 2012
20
"Keeping Up With The Joneses": Proposed Amendment To The Food And Drug Regulations Seeks To Extend Good Manufacturing Practices Requirements To All Active Ingredients
An amendment to the Food and Drug Regulations has been proposed that would extend the good manufacturing practices (GMP) requirements for drugs to all active ingredients (AI); extend drug establishment licensing requirements to those carrying out various activities involving AI; and create a new record-keeping requirement to facilitate the ability to trace AI from the original fabricator to the dosage-form drug manufacturer.
Canada
14 Oct 2012
Links to Result pages
 
1 2  
>>Next